Table 5.

Recommended Surveillance for Individuals with RERE-Related Disorders

System/ConcernEvaluationFrequency
Neurodevelopment Monitor developmental progress & educational needs.At least annually
Neurologic Monitor those w/seizures as clinically indicated.As needed
Psychiatric Behavioral assessment for anxiety, attention, or self-injurious behavior
Eyes Ophthalmologic evalAnnually or as clinically indicated
Hearing Audiologic eval
Cardiovascular Routine follow up w/cardiologistAs indicated for individuals w/congenital heart defects
Genitourinary Routine follow up w/urologistAs clinically indicated for those w/genitourinary issues
Musculoskeletal Clinical assessment for scoliosisAt least annually, until growth is complete

From: RERE-Related Disorders

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.